Issue link: http://www.e-digitaleditions.com/i/730359
Inhalation OCTOBER2016 23 Pre-formulation to commercialization From pre-formulation to commercialization, Catalent Pharma Solutions can assist in any stage of development for inhalation and nasal drug products. Catalent's exper- tise and experience have been successfully applied to multiple dosage forms, as have Catalent Micron Tech- nology's particle size reduction capabilities, which can work to the most stringent specifications demanded by inhalation formulations. Catalent's inhalation manufac- turing operations have a track record of regulatory excel- lence and they routinely manufacture pMDIs, DPIs and nasal formulations for clients around the globe. Catalent Pharma Solutions US: +1 888 SOLUTION www.catalent.com/inhalation more than 70 project experts Medicon Valley Inhalation Consortium (MVIC) is a con- tract research organization (CRO) and partner with more than 70 project managers and specialists in discovery, for- mulation, regulatory, device and product development. MVIC is often seen as a preferred CRO and selected as strategic partner in inhalation product development and inhalation technology. MVIC is located in Lund, a part of Southern Sweden with a cluster of universities, hospitals and pharmaceutical industries. MVIC Sweden: +46 760 160 270 www.mvic.se SPECIALSECTION instruments This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. inhalation technology portfolio Capsugel's recent investments and acquisitions have advanced its integrated approach to drug design and deliv- ery via inhalation. Innovative drug products are developed for dry powder inhaler (DPI) devices based on the com- pany's unique combination of particle engineering capa- bilities, premier spray drying expertise and customized DPI-grade capsules. Particle engineering, utilizing spray dry technology as well as micronization and nano-milling processes, supports pulmonary and nasal drug develop- ment from concept to commercialization. Capsugel US: +1 864 942-3063 www.capsugel.com SPECIALSECTION outsourcing This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Product development and compliant manufacture Hovione offers development and compliant manufac- ture of innovative new drugs and niche generic active pharmaceutical ingredient (API) products. Hovione also supports highly potent compounds and offers pro- prietary product development and licensing opportu- nities for drug products. The company undertakes for- mulation development and clinical supply of final dosage forms to Phase II. With strong expertise in pul- monary delivery, Hovione offers APIs for inhalation, DPI devices, particle engineering and formulation development. Hovione Portugal: +351 21 982 9000 www.hovione.com